Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06294106
Other study ID # 24-212
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 10, 2024
Est. completion date April 2026

Study information

Verified date June 2024
Source Virginia Polytechnic Institute and State University
Contact Jessica Florig, MPH
Phone 540-526-2261
Email jnw@vtc.vt.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A battery of physiological and behavioral data will be collected before and after application of eTMS. Participants will be veterans or first responders diagnosed with PTSD. Study will be a double-blind, sham-controlled, parallel group, randomized clinical trial.


Description:

Veterans and first responders diagnosed with PTSD will be studied to evaluate safety and efficacy of an EEG personalized TMS paradigm. All participants will undergo 2 days of extensive testing prior to eTMS application and 2 days of testing after. Testing will include MRI, OPM, EEG, behavioral tasks, questionnaires, and an EEG sleep study.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date April 2026
Est. primary completion date April 2026
Accepts healthy volunteers No
Gender All
Age group 22 Years to 65 Years
Eligibility Inclusion Criteria: - Veteran or first responder - diagnosed with post-traumatic stress disorder with PCL-5 cutoff of 31 or above Exclusion Criteria: - Claustrophobia - Contraindications to MRI - Pregnant - Uncontrolled medical, psychological, or neurological conditions - Unable to calculate EEG alpha frequency - History of ECT or rTMS - History of intracranial lesion or increased intracranial pressure - History of stroke - History of other neurologic conditions - Family history of epilepsy - Personal history of epilepsy - certain medications

Study Design


Intervention

Device:
Electroencephalogram personalized Transcranial Magnetic Stimulation (eTMS)
EEG is utilized to determine a personalized frequency to then apply TMS to the frontal lobe.

Locations

Country Name City State
United States Fralin Biomedical Research Institute Roanoke Virginia

Sponsors (2)

Lead Sponsor Collaborator
Virginia Polytechnic Institute and State University Wave Neuroscience

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Adverse Events Adverse event reports (or lack-of) will determine device safety Up to 7 weeks
Primary Report of Symptoms Symptom questionnaire to be completed before and after all study procedures to determine feasibility in this patient population. Various symptoms will be rated on a likert scale from absent to severe. Up to 7 weeks
Secondary PCL-5 Completion of the PTSD symptom questionnaire. Scores range from 0-80, with a PTSD cutoff score of 31. Up to 7 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05915013 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response Phase 1
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Recruiting NCT05934162 - Efficacy of Internet-delivered Cognitive-behavior Therapy for PTSD N/A
Recruiting NCT05934175 - Intensive Treatment Versus Standard Weekly Prolonged Exposure for Adults With Post-Traumatic Stress Disorder N/A
Completed NCT04460014 - Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT N/A
Completed NCT05877807 - Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
Active, not recruiting NCT05992649 - The Effect of Aquatic Physiotherapy on Veterans Suffering From PTSD - a 40-week Pilotproject N/A
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Not yet recruiting NCT05331534 - Effect of Attentional Therapy on Post-traumatic Stress Disorder N/A
Not yet recruiting NCT04076215 - Biochemical and Physiological Response to Stressogenic Stimuli N/A
Not yet recruiting NCT03649607 - Accelerated Resolution Therapy for HIV Positive African, Caribbean and Black N/A
Not yet recruiting NCT02545192 - A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments Phase 1
Completed NCT02329418 - Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit N/A
Active, not recruiting NCT00978484 - A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder Phase 3
Completed NCT00760734 - Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD) Phase 1
Completed NCT03278171 - Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit
Recruiting NCT05874362 - People Bereaved by Violent Death : Negative Event Biases and Temporal Perception N/A
Terminated NCT03898843 - Assisted Animal Therapy: ReAnimal N/A
Recruiting NCT04747379 - Psychological Effect of Explicit Recall After Sedation (PEERS)
Completed NCT03248167 - Cannabidiol as a Treatment for AUD Comorbid With PTSD Phase 1/Phase 2